Definium Therapeutics, Inc. (DFTX)
40.97
-2.85
(-6.50%)
USD |
NASDAQ |
Aug 28, 16:00
41.01
+0.04
(+0.10%)
After-Hours: 18:12
Definium Therapeutics Price : 40.97 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | 44.18 | 44.97 | 43.33 | 43.82 | 1.417M |
| Aug 26, 2026 | 44.73 | 45.04 | 43.35 | 43.77 | 1.599M |
| Aug 25, 2026 | 43.97 | 45.31 | 43.62 | 44.81 | 1.271M |
| Aug 24, 2026 | 44.46 | 44.46 | 41.25 | 43.27 | 1.727M |
| Aug 21, 2026 | 45.89 | 46.57 | 44.80 | 44.91 | 1.355M |
| Aug 20, 2026 | 45.11 | 45.59 | 44.20 | 45.40 | 1.662M |
| Aug 19, 2026 | 47.00 | 47.29 | 44.59 | 45.82 | 1.748M |
| Aug 18, 2026 | 45.34 | 46.37 | 44.19 | 46.18 | 2.009M |
| Aug 17, 2026 | 42.20 | 45.32 | 42.04 | 45.26 | 2.278M |
| Aug 14, 2026 | 43.00 | 43.74 | 42.01 | 42.63 | 1.709M |
| Aug 13, 2026 | 44.00 | 45.11 | 42.91 | 43.90 | 2.664M |
| Aug 12, 2026 | 47.51 | 47.55 | 42.42 | 42.79 | 7.636M |
| Aug 11, 2026 | 45.47 | 45.60 | 40.62 | 40.91 | 3.362M |
| Aug 10, 2026 | 45.85 | 45.96 | 43.51 | 45.15 | 2.311M |
| Aug 07, 2026 | 46.30 | 49.70 | 44.24 | 46.14 | 2.547M |
| Aug 06, 2026 | 44.39 | 46.18 | 44.30 | 46.14 | 1.782M |
| Aug 05, 2026 | 42.50 | 44.52 | 42.06 | 44.39 | 1.562M |
| Aug 04, 2026 | 42.65 | 43.08 | 41.86 | 42.32 | 1.862M |
| Aug 03, 2026 | 42.87 | 43.52 | 41.51 | 41.79 | 1.903M |
| Jul 31, 2026 | 44.98 | 45.00 | 42.84 | 43.52 | 1.966M |
| Jul 30, 2026 | 42.29 | 44.70 | 42.27 | 44.49 | 1.808M |
| Jul 29, 2026 | 42.00 | 42.86 | 41.08 | 42.16 | 1.771M |
| Jul 28, 2026 | 42.35 | 42.41 | 40.29 | 41.96 | 1.949M |
| Jul 27, 2026 | 43.65 | 45.42 | 41.73 | 42.65 | 1.557M |
| Jul 24, 2026 | 43.90 | 44.31 | 42.69 | 43.17 | 1.118M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.11 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0003 |
| Arvinas, Inc. | 9.17 |
| Fulcrum Therapeutics, Inc. | 3.855 |
Price Related Metrics
| PEG Ratio | -0.0883 |
| Price to Book Value | 5.992 |
| Earnings Yield | -8.39% |
| Market Cap | 5.505B |
| PEGY Ratio | -0.0883 |